NeuroPace, Inc.
NPCE · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 22.1% | 43.7% | 0.7% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 73.9% | 73.6% | 71.4% | 74% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -20.7% | -34.9% | -80.3% | -62.8% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -34% | -50.4% | -103.4% | -79.9% |
| EPS Diluted | -0.93 | -1.27 | -1.91 | -2.17 |
| % Growth | 26.8% | 33.5% | 12% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |